{"id":"W2900447792","doi":"10.1111/dom.13573","title":"CANadian CAnagliflozin REgistry: Effectiveness and safety of canagliflozin in the treatment of type 2 diabetes mellitus in Canadian clinical practice","year":2018,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"ca_institutions":"LMC Diabetes & Endocrinology (Canada); Mount Sinai Hospital; University of Waterloo; McGill University Health Centre; University of British Columbia; Diabetes Canada; University of Toronto; University of Manitoba","funders":"Mitsubishi Tanabe Pharma Corporation; European Foundation for the Study of Diabetes; Diabetes Canada; Janssen Research and Development; American Diabetes Association","keywords":"Canagliflozin; Medicine; Glycated hemoglobin; Clinical endpoint; Type 2 Diabetes Mellitus; Regimen; Internal medicine; Weight loss; Diabetes mellitus; Adverse effect; Type 2 diabetes; Body mass index; Blood pressure; Renal function; Weight change; Surgery; Endocrinology; Clinical trial; Obesity","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004390739,0.0004497553,0.000892278,0.002626583,0.001350637,0.001490805,0.001690463,0.0005786976,0.004538815],"category_scores_gemma":[0.01590367,0.0003387431,0.0006396787,0.008350221,0.0004740443,0.0005114175,0.0006920439,0.0006013168,0.000464576],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.03712936,"about_ca_system_score_gemma":0.07140405,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.98625,"about_ca_topic_score_gemma":0.9881121,"domain_scores_codex":[0.9948697,0.0005440534,0.0004151014,0.0005847971,0.003097266,0.0004891159],"domain_scores_gemma":[0.9760969,0.001724167,0.004085569,0.000714286,0.01464869,0.002730394],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.00424156,0.0003270035,0.7392343,0.00170593,0.001062765,0.0001406493,0.0003733335,0.001666062,0.0003073212,0.001009895,0.1275131,0.1224181],"study_design_scores_gemma":[0.001331953,0.0003128415,0.9697565,0.000334962,0.0005390755,0.0001177164,0.0001637932,0.002244972,0.0002316968,0.00008165481,0.02481776,0.00006713559],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.6138113,0.02336536,0.002158586,0.007953734,0.0003976025,0.002267807,0.2962276,0.0006575064,0.0531604],"genre_scores_gemma":[0.8945657,0.006911441,0.003995936,0.001841654,0.0001699358,0.0007094452,0.08667988,0.00009808974,0.005027905],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.03712936,"threshold_uncertainty_score":0.2693936,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01293183676837284,"score_gpt":0.2841871140611043,"score_spread":0.2712552772927315,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}